In a pivotal moment for the American cannabis sector, the U.S. Department of Health and Human Services (HHS) has proposed a reclassification of cannabis to the DEA. This could shift cannabis from its current Schedule I status, bringing potential upheaval in the perception and market dynamics of the plant.
The U.S. Department of Health & Human Services (HHS) has recommended that marijuana be moved from Schedule I to Schedule III under federal law. This decision has widespread implications for the cannabis market's trajectory in 2024, touching on diverse areas ranging from policy and business to the very science underpinning such classifications. The change in classification is not just a regulatory adjustment. For stakeholders in the cannabis industry, this decision signifies an acknowledgment of
Health officials are recommending the Drug Enforcement Administration lower the restrictions around cannabis kwtx.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kwtx.com Daily Mail and Mail on Sunday newspapers.
Health officials are recommending the Drug Enforcement Administration lower the restrictions around cannabis witn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from witn.com Daily Mail and Mail on Sunday newspapers.